Conmed Corp (NYSE: CNMD) is -37.69% lower on its value in year-to-date trading and has touched a low of $61.05 and a high of $117.27 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CNMD stock was last observed hovering at around $65.26 in the last trading session, with the day’s gains setting it 2.98%.
Currently trading at $68.24, the stock is 6.21% and -1.74% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.79 million and changing 4.57% at the moment leaves the stock -7.92% off its SMA200. CNMD registered -29.98% loss for a year compared to 6-month loss of -2.68%. The firm has a 50-day simple moving average (SMA 50) of $69.4504 and a 200-day simple moving average (SMA200) of $74.1078.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.20% gain in the last 1 month and extending the period to 3 months gives it a -0.63%, and is 9.52% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.49% over the week and 3.24% over the month.
Conmed Corp (CNMD) has around 4000 employees, a market worth around $2.10B and $1.27B in sales. Current P/E ratio is 21.71 and Fwd P/E is 14.10. Profit margin for the company is 7.75%. Distance from 52-week low is 11.78% and -41.81% from its 52-week high. The company has generated returns on investments over the last 12 months (5.34%).
The EPS is expected to grow by 16.85% this year
389.0 institutions hold shares in Conmed Corp (CNMD), with institutional investors hold 120.69% of the company’s shares. The shares outstanding are 30.77M, and float is at 29.95M with Short Float at 8.21%. Institutions hold 120.01% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 4.99 million shares valued at $346.2 million. The investor’s holdings represent 16.2254 of the CNMD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 3.49 million shares valued at $241.63 million to account for 11.3248 of the shares outstanding. The other top investors are EARNEST PARTNERS LLC which holds 2.82 million shares representing 9.1573 and valued at over $195.39 million, while CAPITAL RESEARCH GLOBAL INVESTORS holds 5.5537 of the shares totaling 1.71 million with a market value of $118.5 million.
Conmed Corp (CNMD) Insider Activity
Conmed Corp disclosed in a document filed with the SEC on Jun 14 ’24 that Peters Stanley W III (President AS and AET) sold a total of 4,000 shares of the company’s common stock. The trade occurred on Jun 14 ’24 and was made at $71.82 per share for $0.29 million. Following the transaction, the insider now directly holds 63.0 shares of the CNMD stock.
Still, SEC filings show that on May 13 ’24, BRONSON DAVID M (Director) acquired 1,350 shares at an average price of $72.09 for $97322.0. The insider now directly holds 16,460 shares of Conmed Corp (CNMD).
